摘要
防御免疫系统的第一道防线是先天性免疫,在很大程度上是一个大家庭的模式识别受体(PRRs)识别为基础的进化保守的分子结构对病原菌叫做病原体相关分子模式(PAMPs)。猪繁殖与呼吸综合征的研究最广泛的家庭是Toll样受体(TLR),它可以引发多种细胞通路配体刺激后。他们在癌症中的作用仍然没有得到解决,因为有M。任何不同的研究显示相反的结果。TLRs一直与肿瘤的进展和免疫抑制相关的以及与细胞凋亡和免疫系统的激活。他们的能力性诱导的凋亡反应和激活先天免疫和适应性免疫,Toll样受体是抗肿瘤治疗发展的一个有趣的药理靶点。有许多研究,包括在本文中审查的临床试验,表明TLR激动剂,特别是结合其他更传统的治疗,如化疗和无线电。治疗,是新开发的治疗方案的有前途的佐剂或成分。然而,研究表明在各种类型的癌症和内源性TLR配体TLR激活原癌基因的后果存在最近的报道越来越多,预警,莫在纳入常规临床实践之前,需要重新研究这一课题。
关键词: Toll样受体,免疫,癌症,治疗,激动剂,临床试验。
Current Medicinal Chemistry
Title:Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy
Volume: 24 Issue: 19
关键词: Toll样受体,免疫,癌症,治疗,激动剂,临床试验。
摘要: The immune system’s first line of defense is innate immunity, largely based on a large family of pattern recognition receptors (PRRs) that recognize evolutionary conserved molecular motifs on pathogens called pathogen-associated molecular patterns (PAMPs). The most extensively studied family of PRRs is Toll-like receptors (TLRs), which can trigger various cellular pathways after ligand stimulation. Their role in cancer is still unresolved as there are many different studies showing contradictory results. TLRs have been associated with both tumor progression and immunosuppression as well as with apoptosis and immune system activation. With their ability to induce apoptotic response and activation of innate and adaptive immunity, TLRs are an interesting pharmacological target for the development of anticancer therapy. There are numerous studies including the clinical trials reviewed in this paper, indicating that TLR agonists, especially combined with other more conventional therapies such as chemotherapy and radiotherapy, are promising adjuvants or components of newly developed treatment regimens. Still, the increasing number of studies indicating protumorigenic consequences of TLR activation in various cancer types and recent reports of the existence of endogenous TLR ligands, forewarn that more studies on this topic are required before their inclusion into regular clinical practice.
Export Options
About this article
Cite this article as:
Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy, Current Medicinal Chemistry 2017; 24 (19) . https://dx.doi.org/10.2174/0929867324666170320114359
DOI https://dx.doi.org/10.2174/0929867324666170320114359 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Changing Role of Radiation in the Post-TME ERA of Rectal Cancer
Current Cancer Therapy Reviews Lycopene and Cardiovascular Diseases: An Update
Current Medicinal Chemistry Toxicogenomics of Cationic Lipid-based Vectors for Gene Therapy: Impact of Microarray Technology
Current Drug Delivery Development of a Reproducible, Sensitive and Rapid Reversed Phase Chromatographic Method for the Estimation of Isotretinoin Incorporated in Bulk Drugs, Pharmaceutical Dosage Forms and Biological Matrix
Current Pharmaceutical Analysis Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Playing Modular Puzzle with Adhesion/Growth-Regulatory Galectins: Design and Testing of a Hybrid to Unravel Structure-Activity Relationships
Protein & Peptide Letters Unexpected Formation of Indenoisoquinoline Derivatives from Thia Analogues of Protoberberine Alkaloids
Letters in Organic Chemistry Interference of Metals and Medications with the Detection of Lipid Peroxidation in Humans by Photometric TBARS Assay
Current Analytical Chemistry Mindfulness Practice for Glycemic Control: Could it be a New Strategy for an Old Problem? A Systematic Review and Meta-Analysis
Current Diabetes Reviews Nanoparticle-Based Diagnosis and Therapy
Current Drug Targets How to Fluorescently Label the Potassium Channel: A Case in hERG
Current Medicinal Chemistry A Facile and Green Synthesis of Novel Imide and Amidic Acid Derivatives of Phenacetin as Potential Analgesic and Anti-Pyretic Agents
Letters in Organic Chemistry Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds
Current Pharmaceutical Design Investigation of the Adsorption Rubraca Anticancer Drug on the CNT(4,4-8) Nanotube as a Factor of Drug Delivery: A Theoretical Study Based on DFT Method
Current Molecular Medicine Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum
Current Pharmaceutical Biotechnology Gold Nanoparticle Based Systems in Genetics
Current Pharmacogenomics Applications of Mannich Reaction in Total Syntheses of Natural Products
Current Organic Chemistry Targeting Triglyceride Metabolism for Colorectal Cancer Prevention and Therapy
Current Drug Targets High Frequency of the Opioid Receptor µ-1 (OPRM1) A118G Polymorphism, an Opioid Drug Therapy Related Gene, in the Indonesian Population
Current Pharmacogenomics and Personalized Medicine